Brickell Biotech, Inc. - FORM 10-K - EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - March 4, 2011

Attached files

file filename
10-K - FORM 10-K - Brickell Biotech, Inc.d10k.htm
EX-31.2 - CERTIFICATION OF JILL M. BROADFOOT, CHIEF FINANCIAL OFFICER - Brickell Biotech, Inc.dex312.htm
EX-10.6 - FIRST AMENDMENT DATED DECEMBER 17, 2010 TO CONSULTING AGREEMENT - Brickell Biotech, Inc.dex106.htm
EX-32.2 - CERTIFICATION OF JILL M. BROADFOOT, CHIEF FINANCIAL OFFICER - Brickell Biotech, Inc.dex322.htm
EX-32.1 - CERTIFICATION OF VIJAY B. SAMANT, CHIEF EXECUTIVE OFFICER - Brickell Biotech, Inc.dex321.htm
EX-31.1 - CERTIFICATION OF VIJAY B. SAMANT, CHIEF EXECUTIVE OFFICER - Brickell Biotech, Inc.dex311.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in the following registration statements:

 

  1) Registration Statements on Form S-3 (333-159103 and 333-164476) of Vical Incorporated, and

 

  2) Registration Statements on Form S-8 (33-60826, 33-60824, 33-81602, 33-81600, 33-87972, 333-30181, 333-80681, 333-60293, 333-66254, 333-97019, 333-107581, 333-116951, 333-135266, 333-143885, and 333-169344) of Vical Incorporated;

of our reports dated March 4, 2011, with respect to the financial statements of Vical Incorporated, and the effectiveness of internal control over financial reporting of Vical Incorporated, included in this Annual Report (Form 10-K) of Vical Incorporated for the year ended December 31, 2010.

/s/ ERNST & YOUNG LLP

San Diego, California

March 4, 2011

Stock widget

Investing forum

Brickell Biotech, Inc. Reports

Also read